GAM Holding’s Bristol-Myers Squibb BMY Stock Holding History

GAM Holding’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-38,000	Closed	-$2.44M	–	352
2019 Q4	$2.44M	Sell	38,000 -2,000	-5%	-$115K	0.12%	213
2019 Q3	$2.03M	Buy	40,000 +35,000	+700%	+$1.64M	0.09%	245
2019 Q2	$227K	Sell	5,000 -32,000	-86%	-$1.49M	0.01%	826
2019 Q1	$1.76M	Buy	+37,000	New	+$1.84M	0.07%	278

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GAM Holding's BMY Position: Q2 2026 in Review

GAM Holding held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 50,869 shares worth $2.93M. The position accounts for 0.22% of the portfolio, ranked #103.

GAM Holding first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $30.7M in Q4 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

GAM Holding held 50,869 shares of Bristol-Myers Squibb worth $2.93M as of Q2 2026.
GAM Holding left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.22% of GAM Holding's portfolio in Q2 2026, its #103 holding.
GAM Holding first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
GAM Holding's Bristol-Myers Squibb position peaked at $30.7M in Q4 2015.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GAM Holding's 13F filing for Q2 2026, filed 14 Aug 2026.